1. Pink Sheet
  2. >>Geography

EC Defends Data Protection Cut As EU ‘Pharma Package’ Nears Crucial Milestone

 
• By Ian Schofield

Proposals to overhaul the general pharmaceutical legislation will ensure that the EU “continues to have one of the most generous systems of incentives in the world,” the European Commission says.

Open cardboard box with a glow inside. Isolated on a transparent background.
The EU's pharmaceutical package is getting a lot of attention • Source: Shutterstock

The European Commission has published a set of “fact sheets” in which it sets out what it sees as the benefits of its proposed reform of the EU pharmaceutical legislation, including the controversial plan to reduce the default period of regulatory data protection (RDP) on new drugs.

The four fact sheets, which also discuss plans to guide drug development towards unmet needs and to tackle drug shortages more effectively, can be seen at least partly as the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

EMA: ‘Sad To See’ Member States Against Patient Engagement Under EU Pharma Reform

 
• By Eliza Slawther

The European Medicines Agency’s chief medical officer Steffen Thistrup argued that patients are able to understand the “complex regulatory and scientific issues” that the EMA committees discuss when they assess drugs.

EU To Track Decentralized Clinical Trials In CTIS To Support Innovation

 
• By Vibha Sharma

Monitoring the use of decentralized elements in clinical trials is a priority for the European medicines regulatory network.

Why Hympavzi Secured English Funding For Hemophilia B But Not Hemophilia A

 
• By Neena Brizmohun

Pfizer told the Pink Sheet it would work with the health technology assessment institute, NICE, with the hope of making Hympavzi available to patients with hemophilia A via the National Health Service.

Autolus’s Aucatzyl And GSK’s Blenrep Among 10 New Drugs To Get EMA Nod

 
• By Vibha Sharma

The European Medicines Agency has OKd 10 new medicines for EU-wide approval, including a CAR-T therapy for treating acute lymphoblastic leukemia. Two drugs were, however, rejected.

More from Geography